Core Lab Q3 revenue $132.1 million, up 6% sequentially but down 2% year over year
Core Laboratories reported third quarter 2026 revenue of $132.1 million, up 6% from the prior quarter but down 2% from a year earlier, with GAAP diluted EPS of $0.12 versus $0.31 in the third quarter of 2025. The company expects fourth quarter revenue of $128.5 million to $134.5 million, roughly flat sequentially, and the Board approved a $0.01 per share quarterly dividend. Profit is well below last year's level, and the outlook points to little change in near-term revenue.
Key points
- Q3 2026 revenue of $132.1 million, up 6% from Q2 2026 and down 2% from $134.5 million in Q3 2025
- GAAP diluted EPS of $0.12 versus $0.31 a year earlier; EPS excluding items of $0.16, down 27% year over year
- Q4 2026 revenue guidance of $128.5 million to $134.5 million, relatively flat sequentially; Q4 EPS expected at $0.12 to $0.20
- Quarterly dividend of $0.01 per share, record date November 9, 2026, payable November 30, 2026
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 28, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.